MATRIX METALLOPROTEINASES (MMPs)

The role of matrix metalloproteinases in aging

“Proteases are a set of enzymes that have been involved in multiple biological processes throughout evolution. Among them, extracellular matrix (ECM) remodeling has emerged as one of the most relevant functions exerted by these proteins, being essential in the regulation of critical events such as embryonic development or tissue homeostasis. Hence, it is not surprising that dysregulation in any protease function that affects ECM homeostasis may contribute to the aging process. Matrix metalloproteinases (MMPs) are one of the most important families of proteases involved in the tight control of ECM remodeling over time. In this review, we will discuss how MMPs and other proteases alter ECM composition and mechanical properties in aging, thereby affecting stem cell niches and the development of senescent phenotypes. Finally, we will summarize recent findings that associate MMPs with the development of age-related diseases, such as neurodegenerative disorders.”

SCIENTIFIC STUDIES

  1. Role of matrix metalloproteinases (MMPs) in colorectal cancer
  2. matrix metalloproteinases (MMPs) in oral diseases
  3. matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
  4. The role of matrix metalloproteinases (MMPs) in human caries
  5. matrix metalloproteinases (MMPs): chemical–biological functions and (Q) SARs
  6. matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair
  7. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma
  8. matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases
  9. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva
  10. Proteolytic events of wound-healing—coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules
  11. matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP–dependent and–independent processes
  12. UVA irradiation stimulates the synthesis of various matrix‐metalloproteinases (MMPs) in cultured human fibroblasts
  13. The matrix metalloproteinases (MMPs) in the decidua and fetal membranes
  14. Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs)
  15. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)
  16. The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?
  17. Expression profile of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in mature human odontoblasts and pulp tissue
  18. Assays of matrix metalloproteinases (MMPs) activities: a review
  19. matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.
  20. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators
  21. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer
  22. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature
  23. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs)
  24. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts
  25. matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs
  26. Screening of novel matrix metalloproteinases (MMPs) in human fetal membranes
  27. Multifaceted role of matrix metalloproteinases (MMPs)
  28. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
  29. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs)
  30. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans
  31. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis
  32. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells
  33. matrix metalloproteinases (MMPs) are required for re-epithelialization of cutaneous wounds
  34. Human odontoblast culture method: the expression of collagen and matrix metalloproteinases (MMPs)
  35. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with …
  36. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T‐cell lymphomas
  37. Tumor necrosis factor alpha (TNF-α) coordinately regulates the expression of specific matrix metalloproteinases (MMPs) and angiogenic factors during fracture …
  38. … to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular …
  39. matrix metalloproteinases (MMPs)
  40. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas
  41. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis
  42. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis
  43. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression
  44. Localization of matrix metalloproteinases (MMPs‐2, 8, 9 and 20) in normal and carious dentine
  45. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-β1
  46. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder.
  47. Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned …
  48. matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine
  49. matrix metalloproteinases (MMPs) safeguard osteoblasts from apoptosis during transdifferentiation into osteocytes: MT1-MMP maintains osteocyte viability
  50. Localization of matrix metalloproteinases,(MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents …
  51. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: A major induction of stromal MMP‐13
  52. Gadolinium chloride reverses dimethylnitrosamine (DMN)-induced rat liver fibrosis with increased matrix metalloproteinases (MMPs) of Kupffer cells
  53. Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis
  54. Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues
  55. Functional role of matrix metalloproteinases (MMPs) in mammary epithelial cell development
  56. Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs)
  57. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and …
  58. Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations
  59. Role of matrix metalloproteinases (MMPs) in tumor invasion and metastasis: serial studies on MMPs and TIMPs
  60. Marrow matrix metalloproteinases (MMPs) and tissue inhibitors of MMP in acute leukaemia: potential role of MMP‐9 as a surrogate marker to monitor leukaemic status …
  61. matrix metalloproteinases (MMPs) in the endometrium of bitches
  62. Measurements of several metallic elements and matrix metalloproteinases (MMPs) in saliva from patients with taste disorder
  63. Relaxed specificity of matrix metalloproteinases (MMPs) and TIMP insensitivity of tumor necrosis factor-α (TNF-α) production suggest the major TNF-α converting …
  64. Seesaw of matrix metalloproteinases (MMPs)
  65. Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor
  66. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology
  67. … medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat …
  68. A quantitative gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure …
  69. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated …
  70. Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: correlation of MMP …
  71. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible …
  72. Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability
  73. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis
  74. The activity of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in mammary tumors of dogs and rats
  75. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis …
  76. Fibrogenesis and carcinogenesis in nonalcoholic steatohepatitis (NASH): involvement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase …
  77. Regulation of matrix metalloproteinases (MMPs) and their inhibitors (TIMPS) during mouse peri-implantation: role of nitric oxide
  78. Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver …
  79. Alcohol Modulation of Cardiac matrix metalloproteinases (MMPs) and Tissue Inhibitors of MMP s Favors Collagen Accumulation
  80. … administration of fucoidan represses cancer metastasis by inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in Lewis tumor …
  81. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic …
  82. Inhalation of organic dusts and lipopolysaccharide increases gelatinolytic matrix metalloproteinases (MMPs) in the lungs of heaves horses
  83. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the …
  84. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility
  85. Advances in assays of matrix metalloproteinases (MMPs) and their inhibitors
  86. Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves
  87. Infrared optical imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia
  88. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs)
  89. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion
  90. Assays of matrix metalloproteinases (MMPs) and MMP Inhibitors
  91. Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs)
  92. Role of matrix metalloproteinases (MMPs) and MMP inhibitors on intracranial aneurysms: a review article
  93. matrix metalloproteinases (MMPs): modern molecular markers of open-angle glaucoma diagnosis and therapy
  94. … bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen …
  95. matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: levels of collagenolytic and gelatinolytic MMPs are low …
  96. Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without …
  97. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT) 1-MMP expressions are …
  98. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells
  99. Is the excessive inhibition of matrix metalloproteinases (MMPs) by potent synthetic MMP inhibitors (MMPIs) desirable in periodontitis and other inflammatory diseases …
  100. Urine matrix metalloproteinases (MMPs) as biomarkers for the progression of fracture healing
  101. Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy
  102. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis
  103. Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor–host interaction in a spontaneous metastasis …
  104. matrix metalloproteinases (MMPs) in liver diseases
  105. Comparison of localized versus systemic levels of matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous …
  106. Vectorial release of matrix metalloproteinases (MMPs) from porcine RPE-choroid explants following selective retina therapy (SRT): towards slowing the macular …
  107. matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria
  108. matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
  109. Fisetin protects liver from binge alcohol-induced toxicity by mechanisms including inhibition of matrix metalloproteinases (MMPs) and oxidative stress
  110. matrix metalloproteinases (MMPs) inhibitory effects of an octameric oligopeptide isolated from abalone Haliotis discus hannai
  111. Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression
  112. The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and …
  113. Changes in the concentration of plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients …
  114. Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic …
  115. matrix metalloproteinases (MMPs) are required for wound closure and healing during larval leg regeneration in the flour beetle, Tribolium castaneum
  116. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial …
  117. Dynamic in vivo changes in the activities of gelatinases, matrix metalloproteinases (MMPs), and tissue inhibitor of metalloproteinases (TIMPs) in buffalo (Bubalus …
  118. Effect of taurine chloramine on the production of matrix metalloproteinases (MMPs) in adiponectin-or IL-1β-stimulated fibroblast-like synoviocytes
  119. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1)
  120. Immunohistochemical study of membrane type-matrix metalloproteinases (MT-MMPs) and matrix metalloproteinase-2 (MMP-2) in dermatofibroma and malignant …
  121. Dynamic expression of matrix metalloproteinases (MMP-2,-9 and-14) and the tissue inhibitors of MMPs (TIMP-1,-2 and-3) at the implantation site during tubal …
  122. The role of matrix metalloproteinases (MMPs) and their inhibitors in venous leg ulcer healing
  123. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers
  124. Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3 …
  125. Polydatin alleviates alcohol-induced acute liver injury in mice: Relevance of matrix metalloproteinases (MMPs) and hepatic antioxidants
  126. … , a novel polypeptide in Ciona savignyi, represses angiogenesis via inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs)
  127. Cranberry (Vaccinium macrocarpon) flavonoids inhibit matrix metalloproteinases (MMPs) in human prostate cancer cells
  128. Spatiotemporal expression of matrix metalloproteinases (MMPs) is regulated by the Ca2+-signal transducer S100A4 in the pathogenesis of thoracic aortic …
  129. Molecular biology of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), and the regulation of these genes in tumor tissues
  130. Inhibition of matrix metalloproteinases (MMPs) by tetracyclines
  131. Inhibitory effects of EGb761 on the expression of matrix metalloproteinases (MMPs) and cartilage matrix destruction
  132. Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas
  133. Differential activity of matrix metalloproteinases (MMPs) during photoperiod induced uterine regression and recrudescence in Siberian hamsters (Phodopus sungorus …
  134. matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS)
  135. Zinc-binding protein-89 (ZBP-89) cooperates with NF-κB to regulate expression of matrix metalloproteinases (MMPs) in response to inflammatory cytokines
  136. Status of research on matrix metalloproteinases (MMPs) in India
  137. matrix metalloproteinases (MMPs) mediate leukocyte recruitment during the inflammatory phase of zebrafish heart regeneration
  138. matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral …
  139. … (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV …
  140. Elevated levels of matrix metalloproteinases-9 and-1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear …
  141. Blood metal levels and third trimester maternal plasma matrix metalloproteinases (MMPs)
  142. Active site specificity profiling datasets of matrix metalloproteinases (MMPs) 1, 2, 3, 7, 8, 9, 12, 13 and 14
  143. matrix metalloproteinases (MMPs) activity in cultured canine bone marrow stromal cells (BMSCs)
  144. matrix metalloproteinases (MMPs) and trophoblast invasion
  145. Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of …
  146. Kaposi’s sarcoma‐associated herpesvirus (KSHV)‐encoded microRNAs promote matrix metalloproteinases (MMPs) expression and pro‐angiogenic cytokine …
  147. matrix metalloproteinases (MMPs), their genetic variants and miRNA in mitral valve diseases: potential biomarker tools and targets for personalized treatments
  148. Alteration in matrix metalloproteinases (MMPs) activity in fibroblast cell line by dexamethasone: a possible mechanism in corticosteroid-induced glaucoma
  149. Development and validation of novel enzyme activity methods to assess inhibition of matrix metalloproteinases (MMPs) in human serum by antibodies against enzyme …
  150. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC) …
  151. Evidence for the involvement of matrix-degrading metalloproteinases (MMPs) in atherosclerosis
  152. Inhibition of matrix metalloproteinases (MMPs) in Siberian hamsters impedes photostimulated recrudescence of ovaries
  153. Imaging of atherosclerosis in vivo using a magnetic resonance contrast probe molecularly targeted to matrix metalloproteinases (MMPs)
  154. Phenotype anchoring in zebrafish reveals a potential role for matrix metalloproteinases (MMPs) in tamoxifen’s effects on skin epithelium
  155. Changes of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in the serum of patients with autoimmune diseases: association with …
  156. The role of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in mesangial matrix replacement in AL-amyloidosis (AL-Am): An-vivo …
  157. … Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of matrix metalloproteinases (MMPs) Expression in Periodontal …
  158. Levels of matrix metalloproteinases (MMPs) in tear fluid of mustard gas exposed patients with chronic dry-eye symptoms
  159. Advances in matrix metalloproteinases (MMPs), membrane-type MMPs, and a disintegrin and metalloproteinase and their roles in cellular interaction and migration
  160. Expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) in experimental systems of cartilage matrix degradation
  161. metalloproteinases (MMPs) of the extracellular matrix in dentistry
  162. Role of matrix metalloproteinases (MMPs) in cystic fibrosis
  163. matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs genetic polymorphisms and plasma levels in hypertensive disorders of pregnancy
  164. CD44 up-regulates the expression of matrix metalloproteinases (MMPs) in ovarian and breast carcinoma cells
  165. The Significance of Expression of matrix metalloproteinases (MMPs) in Intimal Hyperplasia after Ballon Injured Rat Aorta
  166. The effects of host derived metalloproteinases on dentin bond and the role of MMPs inhibitors on dentin matrix degradation
  167. matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for …
  168. Dynamics of activities of matrix metalloproteinases-9 and-2, and the tissue inhibitors of MMPs in fetal fluid compartments during gestation and at parturition in the mare
  169. Differential expression of matrix metalloproteinases (MMPs) in lung cancer metastasis
  170. matrix metalloproteinases (MMPs) and Cytokines in Rheumatology
  171. Differential Gene Expression of matrix metalloproteinases (MMPs) in an Oxidative Stress Model of Cataract
  172. Expression of matrix metalloproteinases (MMPs) and Their Natural Tissue Inhibitors (TIMPs) Following Retinal Ischemia-Reperfusion in Rats
  173. Roles of matrix metalloproteinases (MMPs) in SM-induced pathologies
  174. Analysis of matrix metalloproteinases (MMPs) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS)
  175. Expression of matrix metalloproteinases (MMPs) in peptic ulcers and in inflammatory bowel disease
  176. IMPACT OF ALTERED EXPRESSION OF matrix metalloproteinases (MMPs) ON THE DEVELOPMENT AND SEVERITY OF DIABETIC RETINOPATHY.
  177. matrix metalloproteinases (MMPs) ACTIVITY AFTER LIVE DONOR ADULT LIVER TRANSPLANTATION (LDALT).
  178. The Collagenases: Novel Roles for matrix metalloproteinases (MMPs) in Invasion and Metastasis
  179. Characteristic expression of connective tissue components and matrix metalloproteinases (MMPs) during the development of pressure ulcerations
  180. Effect of fucoidan on mRNA and promoter activity of matrix metalloproteinases (MMPs) in skin fibroblasts
  181. Sub-Threshold Q-Switched Laser (Ellex 2RT)-Induced Migration of Human RPE and Concomitant Release of matrix metalloproteinases (MMPs)
  182. The ectoenzyme-side of matrix metalloproteinases (MMPs) makes inflammation by serum amyloid A (SAA) and chemokines go round
  183. Analysis of the polymorphic variants of genes involved in miRNA pathway and its impact on matrix metalloproteinases (MMPs) in pathogenesis of primary open angle …
  184. Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced …
  185. Hypoxia-regulated proteins (HRPs) and matrix metalloproteinases (MMPs) in gastric cancer: impact on malignant progression
  186. The role and control of matrix metalloproteinases (MMPs) in equine cutaneous wounds: a focus on both endogenous and exogenous proteases
  187. Identification and localization of matrix metalloproteinases (MMPs) present within the aqueous humor and iridocorneal drainage angle tissue of normal and …
  188. matrix metalloproteinases-9 (MMPs-9) and-12 are upregulated in the airways of mice with chronic airway inflammation and remodeling
  189. O-126 Expression profiling of matrix metalloproteinases (MMPs) and inhibitors reveals a novel prognostic role for MMP-19 in patients with non-small cell lung …
  190. matrix metalloproteinases (MMPs)
  191. Inhibition of matrix metalloproteinases (MMPs)
  192. Effect of human chorionic gonadotrophin on membrane type matrix metalloproteinases (MT-MMPs) and tissue inhibitors of metalloproteinase (TIMPs) expression in …
  193. matrix metalloproteinases (MMPs) and pancreatic diseases
  194. Matrix-metalloproteinases (MMPS) in Astroglial Cells
  195. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions
  196. matrix metalloproteinases (MMPs) Concentration in Tears of Eyes with Filtering Blebs
  197. SURVEY OF matrix metalloproteinases (MMPs) IN TUMOUR CELLS AND NORMAL FIBROBLASTS
  198. 9. matrix metalloproteinases (MMPs) as Therapeutic Targets
  199. matrix metalloproteinases (MMPs) in Oral Squamous Cell Carcinoma
  200. DEGENERATION OR REMODELLING: matrix metalloproteinases (MMPs) IN THE TORN ROTATOR CUFF
  201. Inhibition of matrix metalloproteinases (MMPs) by tetracyclines
  202. Differential Gene Expression of the matrix metalloproteinases (MMPs) and Their Inhibitors the Tissue Inhibitors of the matrix metalloproteinases (TIMPs) in the Human …
  203. Atherosclerosis, Matrix-metalloproteinases (MMPs) and Ischemia/Hypoxia
  204. matrix metalloproteinases (MMPs) as Cancer Therapeutic Targets
  205. ASTHMATIC PREGNANT FEMALES; EXPRESSION OF matrix metalloproteinases (MMPs).
  206. Program/Abstract# 307 Expression of matrix metalloproteinases (MMPs) during axolotl limb regeneration
  207. Changes in matrix metalloproteinases (MMPs) and Tissue Inhibitors of MMPs Plasma Profiles in Stress-Induced Cardiomyopathy
  208. Peroxynitrite and nitrosative stress in heart failure: Role of matrix metalloproteinases (MMPs) and poly (ADP)-ribose polymerase (PARP)
  209. Mobility of matrix metalloproteinases (MMPs) in the Ageing Human Bruch’s Membrane
  210. CytoskeletonP614Activity and expression profiling of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in the hearts with …
  211. Inhibition of matrix metalloproteinases (MMPs) and invasion of human glioblastoma (U87MG) cells by isoflavones
  212. Roles of matrix metalloproteinases (MMPs) in SM-induced pathologies
  213. Endothelin–1–Mediated Signaling in the Expression of matrix metalloproteinases (MMPs) and Tissue Inhibitors of metalloproteinases (TIMPs) in Astrocytes
  214. Activation of stroma-derived matrix metalloproteinases (MMPs) in a model of gastric cancer.
  215. Assaying endogenous matrix metalloproteinases (MMPs) in acid-etched dentinal cavity walls
  216. 5. matrix metalloproteinases (MMPs) in Homeostasis and Health: Can MMPs be Good for You?
  217. matrix metalloproteinases (MMPs) in patients with pulmonary tuberculosis (PT) and comorbid COPD
  218. Effect of LIF on expression of matrix metalloproteinases (MMPs) in cultured mouse embryo
  219. The role of matrix metalloproteinases (MMPs) and CTNNB1 mutations in endometrial carcinoma
  220. The History of matrix metalloproteinases (MMPs): Milestones, Myths, and (Mis) Perceptions 2
  221. Elevation of IL-1β and matrix metalloproteinases (MMPs) in radiation induced mouse dermatitis and fibrosis.
  222. Immunohistochemical expression of matrix metalloproteinases (MMPs) in rat mammary tumors.
  223. Laser Mediated Activation Of Human Retinal Pigment Epithelial (rpe) Cells And Concomitant Release Of matrix metalloproteinases (MMPs)
  224. Oncostatin M-Mediated Regulation of matrix metalloproteinases and Associated Mediators of MMPs’ Expression in H-ras Transformed Fibroblasts
  225. Atorvastatin, sildenafil and their combination down-regulate matrix metalloproteinases (MMPs) in 2K1C hypertension
  226. Influence of electroporation on matrix metalloproteinases (MMPs) pattern activity in malignant glioma cells propagated ex vivo
  227. The effect of levocarnitine for plasmatic matrix metalloproteinases (MMPs) on acute cerebral infarct patients.
  228. CAN LEVELS OF URINARY matrix metalloproteinases (MMPs) ACT AS AN ALTERNATIVE TO GLEASON’S SCORING IN PROSTATIC …
  229. Expression of membrane-type matrix metalloproteinases (MT-MMPS) in head and neck squamous cell carcinomas, a target for prodrug development
  230. The role of matrix metalloproteinases (MMPs) in pathophysiology of uterine adenomyosis: state of the art.
  231. Oxidative Stress Inactivates the Proteasome and Decreases the Expression of matrix metalloproteinases (MMPs) and Their Inhibitors (TIMPs) in RPE
  232. Plasma matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs and aging and lifelong exercise adaptations in ventricular and arterial stiffness
  233. PGF2-Induced Signaling Mechanisms Involved in the Activation of ERK1/ERK2 and matrix metalloproteinases (MMPs) in Human Ciliary Muscle (HCM) Cells
  234. Brevican is degraded by matrix metalloproteinases (MMPs) and aggrecanase-1 (ADAMTS4) at the different sites
  235. The possible function of matrix metalloproteinases (MMPs) in MSCs differentiation towards the required type of cells.
  236. Bronchoalveolar Lavage (BAL) matrix metalloproteinases (MMPs) from Pulmonary Alveolar Proteinosis Patients (PAP) Processes BAL MCP-3.
  237. Visualizing the Spatial Localization of Active matrix metalloproteinases (MMPs) using MALDI Imaging MS
  238. Regulation of matrix metalloproteinases (MMPs) by ErbB 2 in MCFIOA Human Breast Epithelial Cells
  239. Progesterone and transforming growth factor beta 1 (TGFB1) regulate matrix metalloproteinases (MMPs) in human endometrium
  240. The Role of matrix metalloproteinases (MMPs) and their Proteolytic Degradation of Chemokines in the Lung
  241. Modulation of lung matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) through the GTP-dependent signal transduction pathway
  242. Progesterone and transforming growth factor Beta 1 (tgfβ1) regulate matrix metalloproteinases (MMPs) in human normal endometrium and endometriosis
  243. Active matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are secreted by neural cells in soluble and non soluble forms.
  244. Spatiotemporal Expression Of matrix metalloproteinases (MMPs) Is Regulated By Ca2+-signal Transducer S100a4 In The Thoracic Aortic Aneurysm Pathogenesis
  245. Expression of matrix metalloproteinases (MMPs-2,-7,-9, and-26) and tissue inhibitors of metalloproteinases (TIMPs-1 and-2) in pleomorphic adenomas and adenoid …
  246. Differential gene expression of matrix metalloproteinases (MMPs), MMP inhibitors (TIMPs and RECK), and MMP-activator (EMMPRIN/CD147) during osteogenic …
  247. Migration of Natural Killer Cells. matrix interaction, locomotion and regulation of matrix metalloproteinases (MMPs) by IL-2 and chemokines
  248. Inhibition of matrix metalloproteinases (MMPs) in Siberian Hamsters (Phodopus sungorus) Impedes Photostimulated Recrudescence of Ovaries.
  249. … ) gene expression in meningioma tissue with the expression of matrix metalloproteinases (MMPs)/tissue inhibitors of matrix metalloproteinase (TIMPs) and …
  250. Inhibition of Cold Ischemia and Reperfusion Injury Mediated by matrix metalloproteinases (MMPs) by NFkB Inhibitor PS-341
  251. The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis
  252. The effect of periodontal flap surgery on matrix metalloproteinases (MMPs) and Tissue inhibitors of matrix metalloproteinase-1 (TIMP-1) levels in gingival crevicular …
  253. Transforming growth factor beta 1 (TGFβ1) and progesterone differentially regulate matrix metalloproteinases (MMPs) in human normal endometrium and …
  254. matrix metalloproteinases (MMPs) and acute phase proteins (APP) in predicting the efficacy of intensive phase treatment (IPP) in patients with pulmonary tuberculosis …
  255. Macrophage Insulin-Like Growth Factor I (IGF1) Reduces matrix metalloproteinases (MMPs), Upregulates Atherosclerotic Plaque Collagen and Suppresses …
  256. Using Small Angle X-Ray Scattering (SAXS) to Characterize the Solution Conformation and Flexibility of matrix metalloproteinases (MMPs)
  257. Understanding the Mechanisms Through Which matrix metalloproteinases (MMPs) Contribute to Breast Cancer-Associated Osteolytic Lesions
  258. Differential gene expression of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are modulated during osteogenic/odontogenic differentiation from …
  259. … of matrix metalloproteinases in serum and cerebrospinal-fluid in children with central nervous system infection and relationship between MMPs and impairment of …
  260. The Role of matrix metalloproteinases (MMPs) in Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Loss in Diabetic Retinopathy: In Vivo and in Vitro Studies
  261. Nociceptive Sensory Neurons (NSNs) Promote Alveolar Macrophages'(AMs) Synthesis of matrix metalloproteinases (MMPs) during Cigarette Smoke (CS) via …
  262. Identification of Ocular matrix metalloproteinases (MMPs) Within the Aqueous Humor Outflow Pathway (Trabecular Meshwork and Uveoscleral Tissues) of Normal …
  263. PROLONGED AGGRECANOLYTIC ACTIVATION OF matrix metalloproteinases (MMPs) RELATIVE TO AGGRECANASES IN A RAT TAIL COMPRESSION …
  264. Proteinase-activated receptor (PAR)-2 stimulates cyclooxygenase-2 (COX-2) expression in Caco-2 colon cancer cells: role of matrix metalloproteinases (MMPs)
  265. Effects of choline treatment in concentrations of serum matrix metalloproteinases (MMPs), MMP tissue inhibitors (TIMPs) and immunoglobulins in an experimental …
  266. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression
  267. matrix metalloproteinases (MMPs) generate angiostatin (AS) in vitro and mouse macrophage elastase (MME) is required for growth of metastasis in vivo
  268. … -e2403 Valsartan attenuates pulmonary arterial hypertension via mitogen-activated protein kinases (MAPKs) signal pathway and matrix metalloproteinases (MMPs) in …
  269. Chamazulene reverses osteoarthritic inflammation through regulation of matrix metalloproteinases (MMPs) and NF-kβ pathway in in-vitro and in-vivo models
  270. … C3H Mice Induced by Cigarette Smoke (CS) Demonstrates Pulmonary Inflammation Concomitant With Increased matrix metalloproteinases (MMPs) and Substance P …
  271. Tissue Engineered Vascular Graft Remodelling in a Growing Lamb Model: Expression of matrix metalloproteinases (MMPs) and Collagen Content in vitro and in vivo
  272. Modulation of matrix metalloproteinases (MMPs) and Their Inhibitors (TIMPs) in Neonatal Lung Disorders by Anti-inflammatory Drugs: Potential Role of GTP …
  273. Gonadotropin and Steroid Regulation of matrix metalloproteinases (MMPs) and Their Endogenous Tissue Inhibitors (TIMPs) in the Developed Corpus Luteum …
  274. Differential influence of IL-1-β, TNF-α, and PDGF-BB on the expression of matrix-metalloproteinases (MMPs) and’total’-MMP activity in early-passage RA-and OA …
  275. Expression of membrane-type matrix metalloproteinases (MT-MMPS) during osteoblast differentiation
  276. THE EXPRESSION AND REGULATION OF MEMBRANE-TYPE matrix metalloproteinases (MT-MMPs) IN PROSTATE
  277. INVOLVEMENT OF MEMBRANE-TYPE matrix metalloproteinases (MT-MMPS) IN CAPILLARY TUBE FORMATION BY HUMAN ENDOMETRIAL …
  278. Regulation of membrane type-matrix metalloproteinases (MT-MMPs) in non-malignant and malignant cells
  279. MMPs and Other Matrix-Degrading metalloproteinases in Neurological Disease
Shopping Cart
Scroll to Top